Related Experiment Videos
Gastric antisecretory 9H-xanthen-9-amines.
Journal of Medicinal Chemistry
|September 1, 1983
Summary
Researchers developed novel 9H-xanthen-9-amines to inhibit gastric acid secretion. Many compounds showed effectiveness in rats, with activity potentially reduced by stomach acid, suggesting new therapeutic avenues for acid-related disorders.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Gastroenterology
Background:
- Gastric acid hypersecretion is a significant factor in various gastrointestinal disorders.
- Developing effective and safe antisecretory agents remains a therapeutic challenge.
Purpose of the Study:
- To synthesize and evaluate a novel series of 9H-xanthen-9-amine derivatives for their gastric antisecretory activity.
- To explore the structure-activity relationship of different nitrogen substituents at the C-9 position.
Main Methods:
- Synthesis of diverse 9H-xanthen-9-amine compounds with various nitrogen substituents.
- In vivo evaluation of gastric acid secretion inhibition in pylorus-ligated rats following oral and intraduodenal administration.
- Assessment of compound stability in gastric juice and in vivo pharmacokinetic analysis in dogs.
Main Results:
- The majority of synthesized 9H-xanthen-9-amine derivatives demonstrated significant inhibition of gastric acid secretion in rats.
- Intraduodenal administration generally enhanced potency compared to oral administration, indicating potential gastric degradation.
- A representative compound showed similar antisecretory effects in dogs, with undetectable blood levels, suggesting rapid tissue binding or metabolism.
Conclusions:
- 9H-xanthen-9-amine derivatives represent a promising class of compounds for managing gastric acid secretion.
- The observed degradation in the gastric environment highlights the importance of formulation and delivery strategies.
- Further investigation into the mechanism of action and active metabolites of these compounds is warranted.